Toxicology of Antimicrobial Aerosols: A Review of Aerosolized Ribavirin and Pentamidine

Food and Drug Administration. Ribavirin aerosol approved for severe cases of RSV in infants and young children. FDA Drug Bull 1986;16:7.

Sidwell RW , Robin RK , Hillard W. Ribavirin: an antiviral agent. Pharmacol Ther 1979;6:123–146.

Sidwell RW , Huffman JH , Khare GP , Allen LB , Witkowski JT , Robins RK . Broad-spectrum antiviral activity of Virazole. Science 1972;177:705–706.

Palmieri G , Ambrosi G , Ferraro G , Agrati AM , Palazzini E. Clinical and immunological evaluation of oral ribavirin administration in recurrent herpes simplex infections. J Int Med Res 1987;15:264–275.

Groothuis JR , Woodin KA , Katz R , Robertson AD , McBride JT , Hall CB , . Early ribavirin treatment of respiratory syncytial viral infection in high-risk children. J Pediatr 1990;117:792–798.

Englund JA , Sullivan CJ , Jordan MC , Dehner LP , Vercellotti GM , Balfour HH Jr . Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med 1988;109:203–208.

McCormick JB , King IJ , Webb PA , Scribner CL , Craven RB , Johnson KM , . Lassa fever: effective therapy with ribavirin. N Engl J Med 1986;314:20–26.

Taber LH , Knight V , Gilbert BE , McClurg HW , Wilson SZ , Norton HJ , . Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatrics 1983;72:613–618.

Hall CB , McBride JT , Walsh EE , Bell DM , Gala CL , Hildreth S , . Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. N Engl J Med 1983;308:1443–1447.

Centers for Disease Control. Management of patients with suspected viral hemorrhagic fever. MMWR 1988;37(S-3):1–6.

Huggins JW . Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug. Rev Infect Dis 1989;11(4, Suppl):750S–761S.

Reichard O , Andersson J , Schvarcz R , Weiland O. Ribavirin treatment for chronic hepatitis C. Lancet 1991;337:1058–1061.

Roberts RB , Dickinson GM , Heseltine PN , Leedom JM , Mansell PW , Rodriguez S , . The Ribavirin-LAS Collaborative Group. A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphadenopathy. JAIDS 1990;3:884–892.

Aschan J , Ringden O , Ljungman P , Andersson J , Lewensohn-Fuchs I , Forsgren M. Influenza B in transplant patients. Scand J Infect Dis 1989;21:349–350.

Anonymous. Ribavirin. In: McEvoy GK , ed. American Hospital Formulary Service drug information. Bethesda MD: American Society of Hospital Pharmacists Inc, 1990:372–379.

Fernandez H , Banks G , Smith R. Ribavirin: a clinical overview. Eur J Epidemiol 1986;2:1–14.

Smith RA , Kirkpatrick W , eds. Ribavirin: a broad-spectrum antiviral agent. New York: Academic Press, 1980.

Smith RA , Knight V , Smith JAD , eds. Clinical application of ribavirin. New York: Academic Press, 1984.

Smee DF , Matthews TR . Metabolism of ribavirin in respiratory syncytial virus-infected and uninfected cells. Antimicrob Agents Chemother 1986;30:117–121.

Patterson JL , Fernand-Larsson R. Molecular mechanisms of action of ribavirin. Rev Infect Dis 1990;6:1139–1146.

ICN Pharmaceuticals Inc. Virazole (ribavirin): prescribing information. Costa Mesa CA: ICN Pharmaceuticals Inc, 1987.

Newth CJ , Clark AR . In vitro performance of the small particle aerosol generator (SPAG-2). Pediatr Pulmonol 1989;7:183–188.

Demers RR , Parker J , Frankel LR , Smith DW . Administration of ribavirin to neonatal and pediatric patients during mechanical ventilation. Respir Care 1986;31:1188–1195.

Knight V , Yu CP , Gilbert BE , Divine GW . Estimating the dosage of ribavirin aerosol according to age and other variables. J Infect Dis 1988;158:443–448.

Englund JA , Piedra PA , Jefferson LS , Wilson SZ , Taber LH , Gilbert BE . High-dose, short-duration ribavirin aerosol therapy in children with suspected respiratory syncytial virus infection. J Pediatr 1990;117:313–320.

Gladu JM , Ecobichon DJ . Evaluation of exposure of health care personnel to ribavirin. J Toxicol Environ Health 1989;28:1–12.

Laskin OL , Longstreth JA , Hart CC , Scavuzzo D , Kalman CM , Connor JD , . Ribavirin deposition in high-risk patients for acquired immunodeficiency syndrome. Clin Pharmacol Ther 1987;41:546–555.

Canonico PG , Kastello MD , Spears CT , Brown JR , Jackson EA , Jenkins DE . Effects of ribavirin on red blood cells. Toxicol Appl Pharmacol 1984;74:155–162.

Ferrera EA , Oishi JS , Sannemacher RW , Stephen EL . Plasma disappearance, urine excretion, and tissue distribution of ribavirin in rats and rhesus monkeys. Antimicrob Agents Chemother 1981;19:1042–1049.

Paroni R , Del Puppo M , Borghi C , Sirtori CR , Galli M. Pharmacokinetics of ribavirin and urinary excretion of the major metabolite in normal volunteers. Int J Clin Pharm Ther Toxicol 1989;27:302–307.

Kramer TH , Gaar GG , Ray CG , Minnich L , Copeland JG , Connor JD . Hemodialysis clearance of intravenously administered ribavirin. Antimicrob Agents Chemother 1990;34:489–490.

Yamada Y , Goto H , Yoshino M , Ogasawara N. IMP dehydrogenase and action of antimetabolites in human cultured blast cells. Biochim Biophys Acta 1990;1051:209–214.

Tricot G , Jayaram HN , Weber G , Hoffman R. Tiazofurin: biological effects and clinical uses. Int J Cell Cloning 1990;8:161–170.

Kini GD , Robins RK , Avery TL . Synthesis and antitumor activity of ribavirin imidates: a new facile synthesis of ribavirin amidine (1-beta-D-ribofuranosyl 1-1,2,4-triazole-3-carboxamine hydrochloride). J Med Chem 1989;32:1447–1449.

Powers CN , Peavy DL , Knight V. Selective inhibition of functional lymphocyte subpopulations by ribavirin. Antimicrob Agents Chemother 1982;22:108–114.

Canonico PG . Efficacy, toxicology, and clinical applications of ribavirin against virulent RNA viral infections. Antiviral Res 1985;(1, Suppl):75–81.

Peavy DL , Koff WC , Hyman DS . Inhibition of lymphocyte proliferative responses by ribavirin. Infect Immun 1980;29:583–589.

Marquardt DL , Gruber HE , Walker LL . Ribavirin inhibits mast cell mediator release. J Pharmacol Exp Ther 1987;240:145–149.

Rosner IK , Welliver RC , Edelson PJ , Geraci-Ciardullo K , Sun M. Effect of ribavirin therapy on respiratory syncytial virus-specific IgE and IgA response after infection. J Infect Dis 1987;155:1043–1047.

Cosgrove M , Jenkins HR , Rowlandson PH , Gray OP . Idiosyncratic reaction to nebulised ribavirin in an artificially ventilated neonate (letter). J Infect 1989;19:85–87.

Janai H. Adverse drug reactions: United States experience. J Pediatr Infect Dis J 1990;9(Suppl):115S–116S.

Hoffman SH , Staffa JA , Smith RA , Craig DK , Parker G. Inhalation toxicity of ribavirin in suckling ferrets. J Appl Toxicol 1987;7:343–351.

Eisenberg J. Hemodynamic alterations in patients treated with ribavirin. Pediatr Infect Dis J 1990;9(Suppl):93S–94S.

Martin JT , Kugler JD , Gumbiner CH , Brown JC , Murphy KR , Colombo JL , . Refractory congestive heart failure after ribavirin in infants with heart disease and respiratory syncytial virus. Nebr Med J 1990;75:23–26.

Janai HK , Marks MI , Zaleska M , Stutman HR . Ribavirin: adverse drug reactions, 1986 to 1988. Pediatr Infect Dis J 1990;9(Suppl):209S–211S.

Gilbert BE , Knight V. Biochemistry and clinical applications of ribavirin. Antimicrob Agents Chemother 1986;30:201–205.

Rodriquez WJ , Kim HW , Brandt CD . Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus disease. Pediatr Infect Dis J 1987;6:159–163.

Rao KP , Rahiman MA . Cytogenic effects of ribavirin on mouse bone marrow. Mutat Res 1989;224:213–218.

Marks MI . Adverse drug reactions: United States experience. Pediatr Infect Dis J 1990;9(Suppl):117S–118S.

Kilham L , Ferm VH . Congenital anomalies induced in hamster embryos with ribavirin. Science 1977;195:413–414.

Kochar DM . Effects of exposure to high concentrations of ribavirin in developing embryos. Pediatr Infect Dis J 1990;9(Suppl):8S–90S.

Kacmarek RM . Ribavirin and pentamidine aerosols: caregiver beware! (editorial). Respir Care 1990;35:1034–1035.

Harrison R , Bellows J , Rempel D , Rudolph L , Kizer KW , Jin A , . Centers for Disease Control. Assessing exposures of health care personnel to aerosols of ribavirin, California. MMWR 1988;36:560–563.

Diamond SA , Dupuis LL . Contact lens damage due to ribavirin exposure (letter). Drug Intell Clin Pharm 1989;23:428–429.

Bradley JS , Connor JD , Compogiannis LS , Eiger LL . Exposure of health care workers to ribavirin during therapy for respiratory syncytial virus infections. Antimicrob Agents Chemother 1990;34:668–670.

Harrison R. Reproductive risk assessment with occupational exposure to ribavirin aerosol. Pediatr Infect Dis J 1990;9(Suppl):102S–105S.

Rodriquez WJ , Dang Bui RH , Connor JD . Environmental exposure of primary care personnel to ribavirin aerosol when supervising infants with respiratory syncytial virus infection. Antimicrob Agents Chemother 1987;31:1143–1146.

Guglielmo BJ , Jacobs RA , Locksley RM . The exposure of health care workers to ribavirin aerosol (letter). JAMA 1989;261:1880–1881.

Charney W , Corkery KJ , Kraemer R , Wugofski L. Engineering and administrative controls to contain aerosolized ribavirin: results of simulation and application to one patient. Respir Care 1990;35:1042–1048.

Wien R. The pharmacological actions of certain aromatic diamidines possessing trypanocidal activity. Ann Trop Med Parasitol 1943;37:1–18.

Van Hoof L , Henrard C , Peel E. Chemoprophylaxis of sleeping sickness by pentamidine. Ann Soc Belge Med Trop 1946;26:371–380.

Anonymous. Pentamidine isethionate. In: McEvoy GK , ed. American Hospital Formulary Service drug information. Bethesda MD: American Society of Hospital Pharmacists Inc, 1990:458–466.

Rosenthal GJ , Corsini E , Craig WA , Comment CE , Luster MI . Pentamidine: an inhibitor of interleukin-1 that acts via a post-translational event. Toxicol Appl Pharmacol 1991;107:555–561.

Perez JM , Navarro-Ranninger MC , Requena JM , Jimenez-Ruiz A , Parrondo E , Craciunescu D , . DNA binding properties and antileukemic (L1210) activity of a Pt-pentamidine complex. Chem Biol Interact 1991;77:341–355.

Bernard EM , Donnelly HJ , Huang A , Tsang S , Armstrong D. Successful prevention and treatment of experimental Pneumocystis carinii pneumonia with aerosol pentamidine (abstract). Paris: 2nd International Conference on AIDS, 1986:54.

Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with the human immunodeficiency virus. MMWR 1989;38(S-5):1–9.

Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus. MMWR 1991;40(RR-2):1–13.

Conte JE , Golden JA . Concentrations of aerosolized pentamidine in bronchoalveolar lavage, systemic absorption, and excretion. Antimicrob Agents Chemother 1988;32:1490–1493.

Farinotti R , Pascaud MB , Girard PM , Guillot E , Certain A , Trouvin JH . Comparison of tissular disposition of pentamidine mesylate in the rat after aerosol or parenteral administration. J Infect Dis 1989;160:507–512.

Donnelly H , Bernard EM , Rothkotter H , Gold JW , Armstrong D. Distribution of pentamidine in patients with AIDS. J Infect Dis 1988;157:985–989.

Conte JE . Pharmacokinetics of intravenous pentamidine in patients with normal renal function or receiving hemodialysis. J Infect Dis 1991;163:169–175.

Berger BJ , Reddy VV , Le ST , Lombardy RJ , Hall JE , Tidwell RR . Hydroxylation of pentamidine by rat liver microsomes. J Pharmacol Exp Ther 1991;256:883–889.

Leoung GS , Feigal DW , Montgomery AB , Corkery K , Wardlaw L , Adams M , . Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia: the San Francisco community prophylaxis trial. N Engl J Med 1990;323:769–775.

Murphy RL , Lavelle JP , Allan JD , Gordin FM , Dupliss R , Boswell WL , . Aerosol pentamidine prophylaxis following Pneumocystis carinii pneumonia in AIDS patients: results of a blinded dose-comparison study using an ultrasonic nebulizer. Am J Med 1991;90:418–426.

Baskin MI , Abd AG , Ilowite JS . Regional deposition of aerosolized pentamidine: effects of body position and breathing pattern. Ann Intern Med 1990;113:677–683.

Sepkowitz KA , Telzak EE , Gold JW , Bernard EM , Blum S , Carrow M , . Pneumothorax in AIDS. Ann Intern Med 1991;114:455–459.

Edelstein H , McCage RE . Atypical presentations of Pneumocystis carinii pneumonia in patients receiving inhaled pentamidine prophylaxis. Chest 1990;98:1366–1369.

Raviglione MC . Extrapulmonary pneumocystosis: the first 50 cases. Rev Infect Dis 1990;12:1127–1138.

Waskin H , Stehr-Green JK , Helmick CG , Sattler FR . Risk factors for hypoglycemia associated with pentamidine therapy for Pneumocystis pneumonia. JAMA 1988;260:345–347.

Schwartz MS , Cappell MS . Pentamidine associated pancreatitis. Dig Dis Sci 1989;34:1617–1620.

Lindley DA , Schleupner CJ . Aerosolized pentamidine and conjunctivitis (letter). Ann Intern Med 1988;109:988.

Berger TG , Tappero JW , Leoung GS , Jacobson MA . Aerosolized pentamidine and cutaneous eruptions. Ann Intern Med 1989;110:1035–1036.

Murphy RL , Noskin GA , Ehrenpreis ED . Acute pancreatitis associated with aerosolized pentamidine. Am J Med 1990;88:53–55.

Chapelon C , Raguin G , DeGennes C. Renal insufficiency with nebulized pentamidine. Lancet 1989;2:1045–1046.

Chen JP , Braham RL , Squires KE . Diabetes after aerosolized pentamidine. Ann Intern Med 1991;114:913–914.

Miller RF , Semple SJ . Bronchial bleeding with nebulised pentamidine (letter). Lancet 1988;2:1488.

Fortunato SJ , Bawdon RE . Determination of pentamidine transfer in the in vitro perfused human cotyledon with high-performance liquid chromatography. Am J Obstet Gynecol 1989;160:759–761.

Harstadd TW , Little BB , Bawdon RE . Embryofetal effects of pentamidine isethionate administered to pregnant Sprague-Dawley rats. Am J Obstet Gynecol 1990;163:912–916.

Montgomery AB , Corkery KJ , Brunette ER , Leoung GS , Waskin H , Debs RJ . Occupational exposure to aerosolized pentamidine. Chest 1990;98:386–388.

Smaldone GC , Vinciguerrra C , Morra L , Marchese J. Urine pentamidine as an indicator of lung pentamidine in patients and health-care workers (abstract). Washington DC: AIDS Clinical Trials Group Meeting, March 1991.

Centers for Disease Control. Guidelines for preventing the transmission of tuberculosis in health care settings with special focus on HIV-related issues. MMWR 1990;39(RR-17):1–29.